JHS Svendgaard Laboratories Limited is an India-based private label manufacturer of oral care products. The Company is engaged in manufacturing a range of oral and dental products for national and international brands. The Company is involved in the manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanitizers and job work of detergent powder. Its domestic market products include toothbrushes, toothpaste, mouthwash, laundry sanitizer, and room fresheners. Its international market products include toothbrush, toothpaste and denture tablet. The Companyâ€™s subsidiary is JHS Svendgaard Mechanical and Warehouse Private Limited.

Employees

263

Sector

Personal Products

More about the company

Quotes

Date	Price	Change	Volume
26-06-12	8.100 ₹	+0.12%	9,073
26-06-11	8.090 ₹	+0.75%	4,444
26-06-10	8.030 ₹	+0.37%	4,107
26-06-09	8.000 ₹	+1.52%	8,134
26-06-08	7.880 ₹	-9.63%	149,380

Delayed Quote Bombay S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-06-12 EDT			5-day change	1st Jan Change
8.100 ^INR	+0.12%		-7.11%	-17.85%

05-26	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-10	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Market Cap	573M 6.02M 5.2M 4.79M 4.49M 8.41M 8.54M 56.6M 22.07M 279M 22.61M 22.12M 965M	P/E Ratio 2024	-8.19x	P/E Ratio 2025	-4.71x
Enterprise Value	452M 4.75M 4.11M 3.78M 3.54M 6.64M 6.74M 44.68M 17.42M 220M 17.84M 17.46M 762M	EV / Sales 2024	1.67x	EV / Sales 2025	0.91x
Free-Float	49.01%	Yield 2024 *	-	Yield 2025	-

05-26	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-10	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-08-12	JHS Svendgaard Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-01	JHS Svendgaard Laboratories Limited Announces Cessation of Mukul Pathak as Independent Director, Effective July 01, 2025	CI
25-03-05	JHS Svendgaard Laboratories Approves Investment Of 50 Mln Rupees In JHS Svendgaard Retail Ventures	RE
25-03-04	JHS Svendgaard Retail Ventures Limited announced that it expects to receive funding from JHS Svendgaard Laboratories Limited, KSS Growth LLP	CI
25-02-13	JHS Svendgaard Laboratories Limited Appoints Paramvir Singh as A Director	CI
25-02-11	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
24-11-13	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
24-08-12	JHS Svendgaard Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
24-08-06	JHS Svendgaard Laboratories Raises INR300 Million via Preferential Issue	MT
24-08-02	JHS Svendgaard Laboratories Limited announced that it has received INR 224.9999 million in funding from COEUS Global Opportunities Fund, M.B. Finmart Private Limited, Milky Investment And Trading Company, Puran Associates Pvt. Ltd., Vic Enterprises Private Limited and another investor	CI

1 day	+0.12%
1 week	-7.11%
Current month	-10.50%
1 month	-10.50%
3 months	-9.80%
6 months	-19.96%
Current year	-17.85%

JHS Svendgaard Laboratories Limited Stock Bombay S.E.

Stocks

532771

INE544H01014

Personal Products

Valuation: JHS Svendgaard Laboratories Limited

Chart: JHS Svendgaard Laboratories Limited

Latest news : JHS Svendgaard Laboratories Limited

Press Releases: JHS Svendgaard Laboratories Limited

Quotes and Performance

Course Extremes

Managers and Directors: JHS Svendgaard Laboratories Limited

Sanitary Products

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	7.85	8.9
1 month	7.85	9.73
Current year	6.15	12.85
1 year	6.15	13.99
3 years	6.15	39.45
5 years	6.15	39.45
10 years	6.15	83.05

Manager	Title	Age	Since
Paramvir Singh Pabla CEO	Chief Executive Officer	47	2010-06-29
Ashish Goel DFI	Director of Finance/CFO	40	2009-04-05
Komal Jhawar CMP	Compliance Officer	-	2022-11-09

Director	Title	Age	Since
Nikhil Nanda BRD	Director/Board Member	53	2004-10-07
Paramvir Singh Pabla BRD	Director/Board Member	47	2024-11-12
Rajagopal C. Venkateish CHM	Chairman	66	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JHS SVENDGAARD LABORATORIES LIMITED	+0.12%	-7.11%	-	-	7.46M
KIMBERLY-CLARK CORPORATION	+0.74%	+3.28%	-23.60%	-24.04%	33.95B
UNICHARM CORPORATION	-0.94%	+1.13%	-21.59%	-50.08%	9.83B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	+0.74%	+1.16%	+11.36%	-30.20%	3.61B
GILLETTE INDIA LIMITED	+0.70%	-0.66%	-24.80%	+69.08%	2.64B
SOFTCARE LIMITED	+0.44%	+1.63%	-	-	2.17B
OIL-DRI CORPORATION OF AMERICA	-1.20%	+12.40%	+64.18%	+272.80%	1.37B
C&S PAPER CO.,LTD	+2.66%	-1.42%	-1.28%	-44.30%	1.31B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	+2.72%	-3.12%	-46.53%	-10.20%	984M
DENCARE (CHONGQING) ORAL CARE CO., LTD.	+4.08%	+5.88%	-43.99%	-14.98%	779M
Average	+1.01%	+3.87%	-10.78%	+21.01%	6.29B
Weighted average by Cap.	+0.51%	+5.27%	-18.94%	-17.28%

	2024	2025
Net sales	729M 7.67M 6.62M 6.1M 5.71M 10.71M 10.87M 72.07M 28.1M 355M 28.78M 28.17M 1.23B	923M 9.71M 8.39M 7.73M 7.23M 13.56M 13.77M 91.25M 35.58M 449M 36.44M 35.66M 1.56B
Net income	-155M -1.63M -1.41M -1.29M -1.21M -2.27M -2.31M -15.29M -5.96M -75.27M -6.11M -5.98M -261M	-197M -2.08M -1.79M -1.65M -1.55M -2.9M -2.95M -19.52M -7.61M -96.1M -7.8M -7.63M -333M
Net Debt	-50.11M -527K -455K -420K -393K -736K -747K -4.95M -1.93M -24.39M -1.98M -1.94M -84.45M	-121M -1.27M -1.1M -1.01M -945K -1.77M -1.8M -11.92M -4.65M -58.69M -4.76M -4.66M -203M